Codice QR

Efficacy and safety of new oral anticoagulants compared with warfarin in cardioembolic prophylaxis of patients with non valvular atrial fibrillation. More lights than shadows

<p>Introduction<br />The prophylaxis of thromboembolic events represents a key point in the modern management of patients with non valvular atrial fibrillation (AF), both paroxysmal and persistent/permanent. Up to now, vitamin K antagonist (VKA) drugs are the first choice in thromboembolic prophylax...

Descrizione completa

Salvato in:
Autori principali: Luca Masotti, Mario Di Napoli, Walter Ageno, Davide Imberti, Daniel Godoy, Grazia Panigada, Niccolò Napoli, Giancarlo Landini, Roberto Cappelli, Ido Iori, Domenico Prisco, Giancarlo Agnelli
Natura: Artigo
Lingua:Inglês
Pubblicazione: PAGEPress Publications 2012-10-01
Serie:Italian Journal of Medicine
Soggetti:
Atrial fibrillation
Stroke
Dabigatran
Rivaroxaban
Apixaban
Accesso online:http://www.italjmed.org/index.php/ijm/article/view/10
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi